Tempest Therapeutics Inc (TPST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 30,268 | 22,116 | 31,124 | 32,326 | 39,230 |
| TOTAL | $31,474 | $23,552 | $31,548 | $33,497 | $40,363 |
| Non-Current Assets | |||||
| PPE Net | 886 | 932 | 1,014 | 920 | 840 |
| Other Non-Current Assets | 9,128 | 9,352 | 9,607 | 9,961 | 10,400 |
| TOTAL | $10,014 | $10,284 | $10,621 | $10,881 | $11,240 |
| Total Assets | $41,488 | $33,836 | $42,169 | $44,378 | $51,603 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 8,863 | 10,284 | 10,108 | 7,619 | 5,243 |
| Accrued Expenses | 4,488 | 2,861 | 3,512 | 2,214 | 3,216 |
| TOTAL | $14,220 | $13,973 | $14,559 | $10,691 | $9,411 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 2,008 | 4,140 | 6,264 |
| Other Non-Current Liabilities | 8,142 | 8,406 | 8,663 | 8,915 | 9,160 |
| TOTAL | $8,142 | $8,406 | $10,671 | $13,055 | $15,424 |
| Total Liabilities | $22,362 | $22,379 | $25,230 | $23,746 | $24,835 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,498 | 3,356 | 1,938 | 1,709 | 1,707 |
| Common Shares | 3 | 27 | 24 | 22 | 22 |
| Retained earnings | -207,106 | -193,293 | -182,737 | -173,167 | -165,263 |
| TOTAL | $19,126 | $11,457 | $16,939 | $20,632 | $26,768 |
| Total Liabilities And Equity | $41,488 | $33,836 | $42,169 | $44,378 | $51,603 |